#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Frontotemporal dementia Acute leukaemia Henoch-Schonlein purpura nephritis Immunodeficiency Chronic lymphocytic leukaemia refractory Congenital leptin deficiency Gastrointestinal neuroendocrine tumour Choroid melanoma Prophylaxis against transplant rejection Neurodegenerative disorder Oesophageal adenocarcinoma stage III Stargardt's disease Carcinoid tumour Progressive multifocal leukoencephalopathy Facioscapulohumeral muscular dystrophy More trials…
Learn about Rare Diseases

Propionic acidaemia – Diagnostics Small intestine leiomyosarcoma VEXAS syndrome Immunodeficiency congenital – Diagnostics Pulmonary sarcoidosis – Treatment Splenic marginal zone lymphoma – Basic Information Alport’s syndrome – Diagnostics Cholangitis sclerosing Primary mediastinal large B-cell lymphoma – Life with Disease Synovial sarcoma recurrent – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Anifrolumab Albiglutide MALIC ACID AZD1163 Barzolvolimab Fosfomycin Trometamol Piperacillin Sodium Ep0031 Tak-280 Adrenaline Acid Tartrate Bp Rizolipase Pyrazinamide Tetrahydrouridine POTASSIUM CLAVULANATE Fludrocortisone Acetate Bisacodyl Nvdx3 Cln-081 Tocotrienol F1245/05 More therapies…

Learn about Your Condition

Urethral stenosis Exposure via breast milk Coronary artery dissection Cervix carcinoma Peyronie's disease Ocular melanoma Bartonellosis Pre-eclampsia Breast neoplasm Breast cancer recurrent Dyslipidaemia Sinusitis bacterial Essential thrombocythaemia Vascular malformation Intracranial calcification More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Breast cancer stage I

Study on Pre-Operative Treatment for Breast Cancer Using Nivolumab, Ipilimumab, and Relatlimab for Patients with Breast Cancer

Recruiting

2 1 1 1
Investigated Drugs:
Study Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Sacituzumab Govitecan
- Pembrolizumab
Study on Pembrolizumab and Paclitaxel for Early Triple-Negative Breast Cancer in Patients with High Tumor-Infiltrating Lymphocytes

Recruiting

2 1 1 1
Investigated Drugs:
- Paclitaxel
- Pembrolizumab
Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Breast cancer stage I

Study on Pre-Operative Treatment for Breast Cancer Using Nivolumab, Ipilimumab, and Relatlimab for Patients with Breast Cancer

Study Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer

Study on Pembrolizumab and Paclitaxel for Early Triple-Negative Breast Cancer in Patients with High Tumor-Infiltrating Lymphocytes

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies